These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8887975)

  • 1. Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo.
    Urwyler S; Campbell E; Fricker G; Jenner P; Lemaire M; McAllister KH; Neijt HC; Park CK; Perkins M; Rudin M; Sauter A; Smith L; Wiederhold KH; Müller W
    Neuropharmacology; 1996 Jun; 35(6):655-69. PubMed ID: 8887975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cells.
    Li JH; Bigge CF; Williamson RM; Borosky SA; Vartanian MG; Ortwine DF
    J Med Chem; 1995 May; 38(11):1955-65. PubMed ID: 7783127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonist--I. Pharmacological characterization in vitro.
    Urwyler S; Laurie D; Lowe DA; Meier CL; Müller W
    Neuropharmacology; 1996 Jun; 35(6):643-54. PubMed ID: 8887974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.
    McAllister KH
    Eur J Pharmacol; 1996 Oct; 314(3):307-11. PubMed ID: 8957251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats.
    Bakshi VP; Tricklebank M; Neijt HC; Lehmann-Masten V; Geyer MA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):643-52. PubMed ID: 9918570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
    Chapman AG; Graham JL; Patel S; Meldrum BS
    Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.
    Parsons CG; Danysz W; Bartmann A; Spielmanns P; Frankiewicz T; Hesselink M; Eilbacher B; Quack G
    Neuropharmacology; 1999 Jan; 38(1):85-108. PubMed ID: 10193901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of competitive NMDA receptor antagonists.
    Cheung NS; O'Callaghan D; Ryan MC; Dutton R; Wong MG; Beart PM
    Eur J Pharmacol; 1996 Oct; 313(1-2):159-62. PubMed ID: 8905343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Baudy RB; Fletcher H; Yardley JP; Zaleska MM; Bramlett DR; Tasse RP; Kowal DM; Katz AH; Moyer JA; Abou-Gharbia M
    J Med Chem; 2001 May; 44(10):1516-29. PubMed ID: 11334562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic analysis of (S)-alpha-amino-5-phosphonomethyl[1,1'-biphenyl]-3-propanoic acid (EAB 515) in brain and blood microdialysate (on-line) and in plasma ultrafiltrate of freely moving rats.
    Malhotra BK; Lemaire M; Brouillard JF; Sawchuk RJ
    J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):167-76. PubMed ID: 8998557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
    Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
    Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).
    Sun L; Chiu D; Kowal D; Simon R; Smeyne M; Zukin RS; Olney J; Baudy R; Lin S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):563-70. PubMed ID: 15075380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of extracellular pH on the potency of N-methyl-D-aspartic acid receptor competitive antagonists.
    Benveniste M; Mayer ML
    Mol Pharmacol; 1992 Oct; 42(4):679-86. PubMed ID: 1435743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
    Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
    Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.